RISA BARTON: Open Payments
NPI 1639379092 · CUMBERLAND, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,494 in 66 payments from 22 companies in 2025. Trend: 2023 $404 · 2024 $702 · 2025 $1,494
Food & beverage: $1,310Education: $184
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $331 |
| Incyte Corporation | 9 | $243 |
| AstraZeneca Pharmaceuticals LP | 8 | $178 |
| Genentech USA, Inc. | 5 | $100 |
| GlaxoSmithKline, LLC. | 3 | $76 |
| Merck Sharp & Dohme LLC | 3 | $75 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $68 |
| PFIZER INC. | 2 | $51 |
| Celgene Corporation | 3 | $50 |
| Eisai Inc. | 2 | $45 |
Products named: ERLEADA, JAKAFI, LYNPARZA, KEYTRUDA, Nubeqa, DARZALEX, RYBREVANT, TECVAYLI.
Industry payments across MD — which companies pay providers there.
